RECORD OF PROCEEDINGS
PHYSICAL DISABILITY BOARD OF REVIEW
BRANCH OF SERVICE: ARMY
SEPARATION DATE: 20020228
NAME: XXXXXXXXXXXXXXXXXXX
CASE NUMBER: PD1201128
BOARD DATE: 20130129
SUMMARY OF CASE: Data extracted from the available evidence of record reflects that this
covered individual (CI) was an active duty SPC/E-4 (91B10/Medical Specialist), medically
separated for fibromyalgia with 11/18 tender points, with chronic pain, daily headache, sleep
disturbance and asthma with normal spirometry. She has low back pain (LBP) that started in
1985 following a motor vehicle accident and exacerbated by a fall down the stairs in 1998. She
was referred to a chronic pain specialist who diagnosed her with severe lumbar neuritis and
possible early fibromyalgia. She also has exercise induced bronchospasm that started in
February 1999 with shortness of breath during physical training. The CI could not be
adequately rehabilitated to meet the physical requirements of her Military Occupational
Specialty (MOS) or satisfy physical fitness standards. She was issued a permanent P3 profile
and referred for a Medical Evaluation Board (MEB). The MEB forwarded early fibromyalgia and
exercise induced bronchospasm as medically unacceptable IAW AR 40-501. Dysmenorrhea,
gastroesophageal reflux disease (GERD), bladder spasms, migraine headaches, scoliosis, sickle
cell trait and seasonal allergic rhinitis conditions, identified in the rating chart below, were also
identified and forwarded by the MEB. The Physical Evaluation Board (PEB) adjudicated the
fibromyalgia and asthma conditions as unfitting, rated 10% and 10% respectively, with
application of the Veteran’s Affairs Schedule for Rating Disabilities (VASRD). The remaining
conditions were determined to be not unfitting and not rated. The CI made no appeals, and
was medically separated with a 20% disability rating.
CI CONTENTION: The CI elaborated no specific contention in her application.
SCOPE OF REVIEW: The Board wishes to clarify that the scope of its review as defined in DoDI
6040.44, enclosure 3, paragraph 5.e. (2) is limited to those conditions which were determined
by the PEB to be specifically unfitting for continued military service; or, when requested by the
CI, those condition(s) “identified but not determined to be unfitting by the PEB.” The ratings
for unfitting conditions will be reviewed in all cases. Any conditions or contention not
requested in this application, or otherwise outside the Board’s defined scope of review, remain
eligible for future consideration by the service Board for Correction of Military Records.
RATING COMPARISON:
Service IPEB – Dated 20011219
VA (7 Mos. Pre -Separation) – All Effective Date 20020301
Condition
Fibromyalgia
Asthma
Dysmenorrhea
GERD
Bladder Spasms
Migraine Headaches
Scoliosis
Sickle Cell Trait
Rating
10%
10%
Code
5025
6602
Not Unfitting
Not Unfitting
Not Unfitting
Not Unfitting
Not Unfitting
Not Unfitting
Condition
Fibromyalgia
Asthma
GERD
Bladder Spasms
Migraine HA
NO VA ENTRY
Code
5025
6602
Rating
20%
10%
Exam
20010726
20010726
7399-7346
7599-7517
8100
10%
0%
0%
20010727
20010726
20010726
NO VA ENTRY
NO VA ENTRY
NO VA ENTRY
0% X 2
Combined: 40%
Seasonal Allergic Rhinitis
Not Unfitting
Combined: 20%
↓No Additional MEB/PEB Entries↓
in DoDI 6044.40, however, resides
20010726
ANALYSIS SUMMARY: The Board notes that the Disability Evaluation System has neither the
role nor the authority to compensate members for anticipated future severity or potential
complications of conditions resulting in medical separation. This role and authority is granted
by Congress to the Department of Veterans Affairs (DVA). The Board utilizes DVA evidence
proximal to separation in arriving at its recommendations; and, DoDI 6040.44 defines a 12-
month interval for special consideration to post-separation evidence. The Board’s authority as
defined
in evaluating the fairness of DES fitness
determinations and rating decisions for disability at the time of separation. Post-separation
evidence therefore is probative only to the extent that it reasonably reflects the disability and
fitness implications at the time of separation.
Fibromyalgia Condition. Fibromyalgia is described in the VASRD as widespread musculoskeletal
pain and tender points with or without fatigue, sleep disturbance, stiffness, paresthesias,
headache, irritable bowel symptoms, depression, anxiety, or Raynaud’s like symptoms. The
rating is based upon the frequency of symptoms without regard to severity or impact on
function. A 10% rating applies when the symptoms are controlled by medication; a 20% rating
applies when the symptoms are episodic, with exacerbations, present more than one third of
the time; a 40% rating applies when symptoms are constant, or nearly so, and refractory to
treatment. At the VA Compensation and Pension (C&P) exam, 7 months prior to separation,
the CI reported body pains, muscle spasms, sleep disturbance, and chronic fatigue. She
reported daily symptoms with some relief with Celebrex, Tylenol #3, Skelaxin, and Vicodin. The
physical examination was significant for 11 tender points. At the time of the narrative summary
(NARSUM) and a rheumatology consultation, 6 months and 4 months prior to separation
respectively, the CI’s symptoms had been present for more than 3 years. These symptoms
included upper and LBP, substernal chest pain, left lower extremity pain, fatigue, sleep
disturbance, paresthesias, and headaches. The CI was on multiple pain medications (anti-
inflammatory and narcotic), muscle relaxants, and an antidepressant for control of her
fibromyalgia symptoms. The CI was placed on a P3 profile with no running, jumping, marching,
or weight bearing greater than 25 pounds. The NARSUM examination noted multiple tender
points at the knees, iliac spines, scapula, chest, and sternum. The rheumatologist indicated that
headaches occurred daily, and that average daily pain severity was 7/10. Medication was noted
to be helpful in reducing the pain severity. One sick slip was in evidence for fibromyalgia
related pain, dated 26 December 2001.
The Board directs attention to its rating recommendation based on the above evidence. The
PEB rated the fibromyalgia condition at 10% coded 5025, while the VA assigned a 20% rating
under the same code. Board members agreed that the 40% criteria were not present in this
case, and debated between a 10% and 20% rating. The Board considered that there were
several entries in the service treatment record describing chronic daily symptoms but that
combined medication therapy was helpful. However, the Board majority concluded that the
paucity of sick slips and the absence of emergency or acute care visits failed to describe a
clinical picture consistent with symptoms “that are episodic, with exacerbations present more
than one third of the time” as required for a 20% rating. Symptoms that “require continuous
medication for control” is considered the most accurate depiction of the condition. After due
deliberation, considering all of the evidence and mindful of VASRD §4.3 (reasonable doubt), the
Board concluded that there was insufficient cause to recommend a change in the PEB
adjudication for the fibromyalgia condition.
Asthma Condition. The NARSUM notes exercise induced bronchospasms diagnosed by a board
certified allergist in 1998. The CI was placed on a permanent profile and treated with as
needed Albuterol.
in evidence, with
documentation of additional ratable criteria, which the Board weighed in arriving at its rating
recommendation; as summarized in the chart below.
There were 3 pulmonary function tests (PFTs)
Pulmonary Exam
FEV1 (% Predicted)
FEV1/FVC
Meds
VA ~7 Mo. Pre-Sep
Pulmonary 2 Mo. Pre-Sep
Pulmonary at Separation
102%
75%
Results pre-bronchodilation
are normal; as needed
Albuterol. Beclovent
115%
72%
96%
73%
As needed Albuterol
As needed Albuterol
§4.97 Rating
10%
10%
10%
Fibromyalgia
Asthma
At the VA Compensation and Pension (C&P) examination 8 months prior to separation, the CI
reported shortness of breath and persistent cough with overexertion, exposure to paint or
smoke, and respiratory illnesses. Her asthma attacks were controlled by rest and use of the
Albuterol and Beclovent. The NARSUM examiner 6 months prior to separation noted that the
only active medication for asthma was an inhaled bronchodilator for exercise induced
bronchospasm. A review of pharmacy records for the year 2001 and an outpatient note on 26
December 2001 (2 months prior to separation) did not indicate that an inhaled steroid
medication was prescribed or being used. The Board directs attention to its rating
recommendation based on the above evidence. Both the PEB and the VA rated the asthma
condition at 10%, for intermittent inhalational bronchodilator therapy and coded 6602, asthma,
IAW VASRD §4.97. There was no evidence in the treatment record for a higher rating of 30%
based on PFTs, daily inhalational or oral bronchodilators or inhalational anti-inflammatory
medications. After due deliberation, considering all of the evidence and mindful of VASRD §4.3
(reasonable doubt), the Board concluded that there was insufficient cause to recommend a
change in the PEB adjudication for the asthma condition.
BOARD FINDINGS: IAW DoDI 6040.44, provisions of DoD or Military Department regulations or
guidelines relied upon by the PEB will not be considered by the Board to the extent they were
inconsistent with the VASRD in effect at the time of the adjudication. The Board did not
surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD
were exercised. In the matter of the fibromyalgia condition, the Board by a vote of 2:1
recommends no change in the PEB adjudication. The single voter for dissent (who
recommended 20%) did not elect to submit a minority opinion. In the matter of the asthma
condition and IAW VASRD §4.97, the Board unanimously recommends no change in the PEB
adjudication. There were no other conditions within the Board’s scope of review for
consideration.
RECOMMENDATION: The Board, therefore, recommends that there be no recharacterization of
the CI’s disability and separation determination, as follows:
UNFITTING CONDITION
VASRD CODE RATING
5025
6602
COMBINED
10%
10%
20%
The following documentary evidence was considered:
Exhibit A. DD Form 294, dated 20120703, w/atchs
Exhibit B. Service Treatment Record
Exhibit C. Department of Veterans’ Affairs Treatment Record
XXXXXXXXXXXXXXXXXXX, DAF
Acting Director
Physical Disability Board of Review
SFMR-RB
MEMORANDUM FOR Commander, US Army Physical Disability Agency
(TAPD-ZB / XXXXXXXX), 2900 Crystal Drive, Suite 300, Arlington, VA 22202-3557
SUBJECT: Department of Defense Physical Disability Board of Review Recommendation
for XXXXXXXXXX, AR20130003777 (PD201201128)
I have reviewed the enclosed Department of Defense Physical Disability Board of
Review (DoD PDBR) recommendation and record of proceedings pertaining to the
subject individual. Under the authority of Title 10, United States Code, section 1554a,
I accept the Board’s recommendation and hereby deny the individual’s application.
This decision is final. The individual concerned, counsel (if any), and any Members of
Congress who have shown interest in this application have been notified of this decision
by mail.
BY ORDER OF THE SECRETARY OF THE ARMY:
Encl
XXXXXXXXXXXXXXXXXXXXXXX
Deputy Assistant Secretary
(Army Review Boards)
AF | PDBR | CY2011 | PD2011-00721
The PEB adjudicated the asthma condition as unfitting, rated 30%; with application of Veterans Administration Schedule for Rating Disabilities (VASRD) and the CI was placed on Temporary Disability Retired List (TDRL) at 30%. Although originally prescribed a daily use inhaled maintenance/preventive medication, the CI elected to discontinue the medication and at final separation there was no indication that a daily-use inhalation preventive medication was used or prescribed. The NARSUM...
AF | PDBR | CY2011 | PD2011-00224
After 12 months of TDRL the asthma condition was considered to be stable, but still unfitting. The Board does not have the authority under DoDI 6040.44 to render fitness or rating recommendations for any conditions not considered by the DES. The Board therefore has no reasonable basis for recommending any additional unfitting conditions for separation rating.
AF | PDBR | CY2014 | PD-2014-02369
SEPARATION DATE: 20051011 Asthma Condition . BOARD FINDINGS : IAW DoDI 6040.44, provisions of DoD or Military Department regulations or guidelines relied upon by the PEB will not be considered by the Board to the extent they were inconsistent with the VASRD in effect at the time of the adjudication.In the matter of the asthma condition, the Board unanimously recommends a disability rating of 30%, coded 6602 IAW VASRD §4.100.In the matter of the contended allergic rhinitis, migraine...
AF | PDBR | CY2012 | PD 2012 01248
The Physical Evaluation Board (PEB) adjudicated the asthma condition as unfitting, rated 10% with application of the Veterans Affairs Schedule for Rating Disabilities (VASRD). The contended conditions adjudicated as not unfitting by the PEB were allergic rhinitis, intermittent non-radiating lower back pain, essential hypertension, chronic gastritis and hypercholesterolemia. Providing a correction to the individuals separation document showing that the individual was separated by reason...
AF | PDBR | CY2012 | PD2012 01083
He was issued a permanent P3 profile andreferred for a Medical Evaluation Board (MEB).Asthma and mild restrictive pattern were forwarded to the Physical Evaluation Board (PEB) as medically unacceptable IAW AR 40-501.The PEB adjudicated the asthma and mild restrictive pattern as unfitting, rated 10% with application of the Veteran’s Affairs Schedule for Rating Disabilities (VASRD).The CI made no appeals, and was medically separated with a 10% disability rating. a month prior to the PEB,...
AF | PDBR | CY2013 | PD-2013-02043
At the MEB examination on 1 October 2003, the CI reported asthma, shortness of breath, bronchitis, wheezing and indicated he used an albuterol inhaler as needed. Pulmonary function studies, including FVC, FEV1-84%, FEV1/FVCratio-86%, were within normal limits. The Board directs attention to its rating recommendationbased on the above evidence.The CI was diagnosed with exercise induced asthma and at the time of separation used an inhalational bronchodilator.
AF | PDBR | CY2012 | PD2012-00289
The narrative summary (NARSUM), service treatment records (STR), and prior to separation VA C&P examination all indicate that the CI required and used daily inhalational bronchodilator and oral medications which would support a 30% rating IAW VASRD code 6602 (“daily inhalational or oral bronchodilator therapy or inhalational anti-inflammatory medication”) and VASRD §4.97. RECOMMENDATION : The Board recommends that the CI’s prior determination be modified as follows; and, that the discharge...
AF | PDBR | CY2013 | PD-2013-02765
The requested sleep apnea, anxiety, hypertension and rhinitis conditions were not identified by the PEB, and therefore not within the DoDI 6040.44 defined purview of the Board.Any conditions or contention not requested in this application, or otherwise outside the Board’s defined scope of review, remain eligible for future consideration by the Board for Correction of Military Records. Asthma Condition . The PEB TDRL exit rating was 10%,with the disability description stating: “not...
AF | PDBR | CY2012 | PD2012 01240
The Board evaluates DVA evidence proximal to separation in arriving at its recommendations, but its authority resides in evaluating the fairness of DES fitness decisions and rating determinations for disability at the time of separation. Asthma Condition .The CI had a history of exercised-induced asthma with running since June 2001 manifested by shortness of breath (SOB), wheezing, and chest discomfort.He reported mild, subjective improvement with an inhaled bronchodilator, which was...
AF | PDBR | CY2011 | PD2011-00784
The VA Compensation and Pension (C&P) exam, 4 months after separation (performed 23 December 2003), indicated “mild asthma requiring Albuterol inhaler PRN” and the only asthma medication the CI was taking was albuterol at a frequency of, “Albuterol inhaler two puffs three times per week when her asthma bothers her. From this evidence and the evidence documented in the CI’s records made available to the Board, the Board majority concluded that the preponderance of evidence suggest the CI did...